With more than 50 percent of its population having received at least one shot of the Covid-19 vaccine, Israel is returning to normality and reopening non-essential services. Now, the country turns to Argentina to help develop its Israeli-made immunizer.
Sergio Urribarri, the Argentinian ambassador to Israel, said on March 8 that Argentina could host the third phase of clinical trials of Israel’s coronavirus vaccine, as well as producing the immunizer. The announcement was made during a meeting with authorities from the Hadassah Hospital and the Israeli Institute for Biological Research.
Mr. Urribari said that “several joint actions were being carried out” between the two countries, “including exchange between health professionals.”
Argentina began its vaccination campaign on December 24 and, as of March 9, more than 1.3 million people have received at least one shot of the vaccine, according to the Health Ministry’s vaccine tracker. Buenos Aires is also expected to produce 150 million doses of the Astrazeneca vaccine in a partnership with Mexico.
Brazilians in Israel
Brazil is also in contact with Israel, but not to purchase or produce vaccines. A senior delegation of Brazilian officials arrived in Israel to discuss purchasing an Israeli-developed nasal spray that Prime Minister Benjamin Netanyahu claims is a “miracle” cure against Covid-19, despite a lack of scientific evidence.
During his time in Israel, Foreign Affairs Minister Ernesto Araújo was scolded by Israeli authorities for beginning a speech without using a face mask. The Brazilian delegation left Brazil without using face coverings, but were forced to use them as soon as they landed in Jerusalem.
Support this coverage →
Search
